These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38819947)

  • 1.
    Yi C; Zang N; Gao L; Ren F
    Aging (Albany NY); 2024 May; 16(11):9498-9517. PubMed ID: 38819947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of
    Lin H; Wang J; Shi Q; Wu M
    PeerJ; 2024; 12():e17338. PubMed ID: 38708353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. System analysis of
    Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
    Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exostosin1 as a novel prognostic and predictive biomarker for squamous cell lung carcinoma: A study based on bioinformatics analysis.
    Wu D; Huo C; Jiang S; Huang Y; Fang X; Liu J; Yang M; Ren J; Xu B; Liu Y
    Cancer Med; 2021 Apr; 10(8):2787-2801. PubMed ID: 33314711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
    Xu XL; Gong Y; Zhao DP
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database.
    Ke D; Guo Q; Fan TY; Xiao X
    Cancer Biother Radiopharm; 2021 Apr; 36(3):280-291. PubMed ID: 33112657
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of RNMT as an immunotherapeutic and prognostic biomarker: From pan-cancer analysis to lung squamous cell carcinoma validation.
    Huang S; Tan C; Zheng J; Huang Z; Li Z; Lv Z; Chen W; Chen M; Yuan X; Chen C; Yan Q
    Immunobiology; 2024 Sep; 229(5):152836. PubMed ID: 39018675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unveiling ficolins: diagnostic and prognostic biomarkers linked to the Tumor Microenvironment in Lung Cancer.
    Zhang Z; Geng X; Yin M; Zhang S; Liu Y; Hu D; Zheng G
    World J Surg Oncol; 2024 Oct; 22(1):273. PubMed ID: 39390580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTR2B as a novel biomarker of chronic obstructive pulmonary disease with lung squamous cell carcinoma.
    Li Y; Wang Y; Wu R; Li P; Cheng Z
    Sci Rep; 2024 Jun; 14(1):13206. PubMed ID: 38851806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune signature of T follicular helper cells predicts clinical prognostic and therapeutic impact in lung squamous cell carcinoma.
    Xu F; Zhang H; Chen J; Lin L; Chen Y
    Int Immunopharmacol; 2020 Apr; 81():105932. PubMed ID: 31836430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential prognostic impact and potential molecular mechanisms of PCDHGA12 expression in lung adenocarcinoma and squamous cell carcinoma.
    Xu X; Zhang J; Yao T; Zhao X; Wu Q; Lu C; Guo X; Xie S; Qiu L; Bi R; Xue H
    Int Immunopharmacol; 2024 Sep; 139():112727. PubMed ID: 39067405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyroptosis-related long-noncoding RNA signature predicting survival and immunotherapy efficacy in patients with lung squamous cell carcinoma.
    Zhan X; Li J; Ding Y; Zhou F; Zeng R; Lei L; Zhang Y; Feng A; Qu Y; Yang Z
    Clin Exp Med; 2024 Jul; 24(1):145. PubMed ID: 38960987
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Zhang Y; Sun Q; Liang Y; Yang X; Wang H; Song S; Wang Y; Feng Y
    Front Immunol; 2024; 15():1424197. PubMed ID: 38983866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of downregulated ADARB1 in lung squamous cell carcinoma.
    Wang X; Ren X; Liu W; Chen X; Wei J; Gong Z; Yan Y; Xu Z
    Mol Med Rep; 2020 Mar; 21(3):1517-1526. PubMed ID: 32016472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative analysis of DNA methylation-driven genes for the prognosis of lung squamous cell carcinoma using MethylMix.
    Li R; Yin YH; Jin J; Liu X; Zhang MY; Yang YE; Qu YQ
    Int J Med Sci; 2020; 17(6):773-786. PubMed ID: 32218699
    [No Abstract]   [Full Text] [Related]  

  • 16. SEPT9: From pan-cancer to lung squamous cell carcinoma.
    Wang W; Zhang X; Gui P; Zou Q; Nie Y; Ma S; Zhang S
    BMC Cancer; 2024 Sep; 24(1):1105. PubMed ID: 39237897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a novel immune-related prognostic model in lung squamous cell carcinoma.
    Liu Z; Wan Y; Qiu Y; Qi X; Yang M; Huang J; Zhang Q
    Int J Med Sci; 2020; 17(10):1393-1405. PubMed ID: 32624696
    [No Abstract]   [Full Text] [Related]  

  • 18. A glycolysis-based three-gene signature predicts survival in patients with lung squamous cell carcinoma.
    Huang G; Zhang J; Gong L; Huang Y; Liu D
    BMC Cancer; 2021 May; 21(1):626. PubMed ID: 34044809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the Lung Squamous Cell Carcinoma Diagnosis and Prognosis Markers by Unique DNA Methylation and Gene Expression Profiles.
    Wang W; Wang S; Chu X; Liu H; Xiang M
    J Comput Biol; 2020 Jul; 27(7):1041-1054. PubMed ID: 31710242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Li Y; Zheng P; Zhan X
    Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.